AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 230 filers reported holding AMICUS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $862 | -4.6% | 70,900 | -1.5% | 0.00% | 0.0% |
| Q2 2023 | $904 | -70.2% | 72,000 | -73.7% | 0.00% | -20.0% |
| Q1 2023 | $3,030 | +343.0% | 273,300 | +387.2% | 0.01% | +66.7% |
| Q4 2022 | $684 | -99.9% | 56,100 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $585,000 | +379.5% | 56,100 | +392.1% | 0.00% | +200.0% |
| Q2 2022 | $122,000 | -93.8% | 11,400 | -86.5% | 0.00% | -87.5% |
| Q4 2020 | $1,953,000 | +132.5% | 84,600 | +42.2% | 0.01% | +100.0% |
| Q3 2020 | $840,000 | +55.0% | 59,500 | +65.3% | 0.00% | +100.0% |
| Q2 2020 | $542,000 | +148.6% | 36,000 | +51.9% | 0.00% | +100.0% |
| Q1 2020 | $218,000 | +120.2% | 23,700 | +132.4% | 0.00% | – |
| Q4 2019 | $99,000 | -38.9% | 10,200 | -50.0% | 0.00% | – |
| Q3 2019 | $162,000 | -31.1% | 20,400 | +7.9% | 0.00% | -100.0% |
| Q2 2019 | $235,000 | +61.0% | 18,900 | +75.0% | 0.00% | 0.0% |
| Q1 2019 | $146,000 | +294.6% | 10,800 | +176.9% | 0.00% | – |
| Q4 2018 | $37,000 | +23.3% | 3,900 | +56.0% | 0.00% | – |
| Q3 2018 | $30,000 | -88.0% | 2,500 | -84.4% | 0.00% | -100.0% |
| Q2 2018 | $249,000 | +37.6% | 16,000 | +32.2% | 0.00% | 0.0% |
| Q1 2018 | $181,000 | +546.4% | 12,100 | +505.0% | 0.00% | – |
| Q4 2017 | $28,000 | -72.5% | 2,000 | -70.6% | 0.00% | – |
| Q3 2017 | $102,000 | – | 6,800 | – | 0.00% | – |
| Q3 2015 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q1 2015 | $314,000 | – | 28,881 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |